Oct

    Structural and Behavioral Remedies in Pharmaceutical Mergers: EU v. US

    12 PM EDT

    The program will focus on remedies in pharmaceutical mergers, with a component focusing on structural remedies and how the FTC and EC find suitable buyers for any divestitures (examining, among other items, the tension between looking for new entrants (in a particular narrowly defined market) and experienced firms to replace lost competition (presumably in a broader segment of the market)). The panel will also explore when behavioral remedies are applied.

    Moderator:
    *Lauren Rackow, Cahill Gordon & Reindel LLP

    Speakers:
    *Robin Adelstein, Norton Rose Fulbright US LLP
    *Gavin Bushell, Baker & McKenzie
    *Arthur Stril, European Commission
    *James Weiss, Federal Trade Commission

    For this and all upcoming events visit https://shop.americanbar.org/eBus/ABAEventsCalendar.aspx

    FREE:  Antitrust Section Members, Government, Non-profit Employees, Students
    $25 Other Non-Members

    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25.   For this and all upcoming events visit http://AmBar.org/ATEvents.
     
    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive
    Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

     


     

     

    $25
    NON-MEMBERS
    $10
    MEMBERS
    $0
    SECTION MEMBERS
    Register Now *Additional discounts may apply at checkout

    Log In to view your rate

    Structural and Behavioral Remedies in Pharmaceutical Mergers: EU v. US

    Event Details

    Format

    Teleconference

    Date

    Oct 29, 2015

    2015-10-29T12:00:00-04:00 2015-10-29T13:00:00-04:00 Structural and Behavioral Remedies in Pharmaceutical Mergers: EU v. US

    The program will focus on remedies in pharmaceutical mergers, with a component focusing on structural remedies and how the FTC and EC find suitable buyers for any divestitures (examining, among other items, the tension between looking for new entrants (in a particular narrowly defined market) and experienced firms to replace lost competition (presumably in a broader segment of the market)). The panel will also explore when behavioral remedies are applied.

    Moderator:
    *Lauren Rackow, Cahill Gordon & Reindel LLP

    Speakers:
    *Robin Adelstein, Norton Rose Fulbright US LLP
    *Gavin Bushell, Baker & McKenzie
    *Arthur Stril, European Commission
    *James Weiss, Federal Trade Commission

    For this and all upcoming events visit https://shop.americanbar.org/eBus/ABAEventsCalendar.aspx

    FREE:  Antitrust Section Members, Government, Non-profit Employees, Students
    $25 Other Non-Members

    Explore Section benefits or call 1-800-285-2221 to join. Code RAT14IP25.   For this and all upcoming events visit http://AmBar.org/ATEvents.
     
    CLE
    The ABA is not seeking CLE credit for this program.

    Audio Archive
    Provided all releases are obtained, MP3 recordings of this program will be available to Section members on the Committee Program Audio page.

     


     

     

    Sponsors

    Health Care and Pharmaceuticals Committee

    Section of Antitrust Law

    Related Products

    Related On-Demand CLE